Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1655
-0.0028(-0.24%)
GBP/USD
1.2549
+0.0016(+0.13%)
Bitcoin GBP
49,252.70
+2,149.02(+4.56%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

JCR Pharmaceuticals Co., Ltd. (JCRRF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

5.22

0.00

(0.00%)

As of 09:42AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	637.65M
Enterprise value	669.34M
Trailing P/E	19.25
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.49
Price/book (mrq)	1.85
Enterprise value/revenue	0.02
Enterprise value/EBITDA	0.09

Trading information

Stock price history

Beta (5Y monthly)	0.01
52-week change ³	-51.46%
S&P500 52-week change ³	22.43%
52-week high ³	10.76
52-week low ³	5.22
50-day moving average ³	7.82
200-day moving average ³	8.85

Share statistics

Avg vol (3-month) ³	1
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	124.8M
Implied shares outstanding ⁶	125.6M
Float ⁸	73.38M
% held by insiders ¹	43.26%
% held by institutions ¹	16.48%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.13
Forward annual dividend yield ⁴	2.53%
Trailing annual dividend rate ³	20.00
Trailing annual dividend yield ³	383.14%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	46.76%
Dividend date ³	N/A
Ex-dividend date ⁴	28 Mar 2024
Last split factor ²	4:1
Last split date ³	30 Sept 2020

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends	31 Mar 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	12.97%
Operating margin (ttm)	9.64%

Management effectiveness

Return on assets (ttm)	5.03%
Return on equity (ttm)	9.93%

Income statement

Revenue (ttm)	41.37B
Revenue per share (ttm)	331.61
Quarterly revenue growth (yoy)	-15.00%
Gross profit (ttm)	N/A
EBITDA	9.87B
Net income avi to common (ttm)	5.36B
Diluted EPS (ttm)	0.27
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	18.3B
Total cash per share (mrq)	146.64
Total debt (mrq)	23.3B
Total debt/equity (mrq)	41.65%
Current ratio (mrq)	1.80
Book value per share (mrq)	445.92

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A